| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
120,416,000 |
| Market
Cap: |
1.02(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.3 - $18 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
816,825 |
| Total Buy Value |
$0 |
$0 |
$0 |
$194,885 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
4 |
| Total Shares Sold |
5,494 |
11,095 |
23,173 |
428,724 |
| Total Sell Value |
$37,156 |
$76,346 |
$174,816 |
$491,653 |
| Total People Sold |
2 |
4 |
6 |
7 |
| Total Sell Transactions |
2 |
5 |
13 |
35 |
| End Date |
2025-04-06 |
2025-01-03 |
2024-07-05 |
2023-07-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Touchon Pascal |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
77,955 |
|
- |
|
| Fust Matthew K |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
18,188 |
|
- |
|
| Gallagher Carol Giltner |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
33,012 |
|
- |
|
| Roncarolo Maria Grazia |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
17,368 |
|
- |
|
| Mallik Ameet |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
16,928 |
|
- |
|
| Heiden William K |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
22,188 |
|
- |
|
| Green Jeremy |
Director |
– • – |
2025-05-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
441,701 |
|
24% |
|
| Huang James |
|
– • • |
2025-05-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,330,665 |
|
24% |
|
| Grant-Huerta Yanina |
Chief Accounting Officer |
• • – |
2025-05-16 |
4 |
S |
$6.76 |
$15,000 |
D/D |
(2,218) |
37,067 |
|
-24% |
|
| Nguyen Anhco |
President and CEO |
• • – |
2025-05-16 |
4 |
S |
$6.76 |
$22,156 |
D/D |
(3,276) |
70,847 |
|
-24% |
|
| Ciongoli Gregory Austin |
See remarks |
– • • |
2025-05-16 |
4 |
A |
$6.61 |
$499,531 |
D/D |
75,572 |
1,209,395 |
|
- |
|
| Grant-Huerta Yanina |
Chief Accounting Officer |
• – – |
2025-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,285 |
|
43% |
|
| Henrich Jill |
EVP, Chief Regulatory Officer |
• • – |
2025-03-03 |
4 |
S |
$7.00 |
$7,410 |
D/D |
(1,059) |
18,679 |
|
-21% |
|
| Hyllengren Eric J |
EVP, CFO and COO |
• • – |
2025-03-03 |
4 |
S |
$7.00 |
$8,473 |
D/D |
(1,211) |
56,231 |
|
-21% |
|
| Nguyen Anhco |
President and CEO |
• • – |
2025-03-03 |
4 |
S |
$7.00 |
$23,307 |
D/D |
(3,331) |
74,123 |
|
-21% |
|
| Hyllengren Eric J |
EVP, CFO and COO |
• • – |
2025-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
34,050 |
57,442 |
|
- |
|
| Hyllengren Eric J |
EVP, CFO and COO |
• • – |
2024-11-18 |
4 |
S |
$11.20 |
$15,274 |
D/D |
(1,364) |
23,392 |
|
47% |
|
| Henrich Jill |
EVP, Chief Regulatory Officer |
• • – |
2024-11-18 |
4 |
S |
$11.20 |
$11,198 |
D/D |
(1,000) |
19,378 |
|
47% |
|
| Nguyen Anhco |
President and CEO |
• • – |
2024-11-18 |
4 |
S |
$11.20 |
$18,633 |
D/D |
(1,664) |
77,454 |
|
47% |
|
| Nguyen Anhco |
President and CEO |
• • – |
2024-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
79,118 |
|
- |
|
| Ciongoli Gregory Austin |
Director |
– • • |
2024-09-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,133,823 |
|
113% |
|
| Touchon Pascal |
President and CEO |
• • – |
2024-08-16 |
4 |
S |
$6.63 |
$20,139 |
D/D |
(3,038) |
70,127 |
|
-90% |
|
| Hyllengren Eric J |
EVP, CFO |
• • – |
2024-08-16 |
4 |
S |
$6.63 |
$7,093 |
D/D |
(1,070) |
24,756 |
|
-90% |
|
| Murugan Amar |
EVP, Chief Legal Officer |
• • – |
2024-08-16 |
4 |
S |
$6.63 |
$7,677 |
D/D |
(1,158) |
26,827 |
|
-90% |
|
| Nguyen Anhco |
EVP, Chief Sci. & Tech Officer |
• • – |
2024-08-16 |
4 |
S |
$6.63 |
$12,072 |
D/D |
(1,821) |
34,118 |
|
-90% |
|
710 Records found
|
|
Page 1 of 29 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.22 (2.61%) 
